Kelsey Danley to Phosphodiesterase 5 Inhibitors
This is a "connection" page, showing publications Kelsey Danley has written about Phosphodiesterase 5 Inhibitors.
Connection Strength
0.680
-
The association of phosphodiesterase-5 inhibitors with the biochemical recurrence-free and overall survival of patients with prostate cancer following radical prostatectomy. Urol Oncol. 2022 02; 40(2):57.e1-57.e7.
Score: 0.680